Artwork for podcast Pathfinders in Biopharma
Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing
Episode 243rd June 2024 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:20:39

Share Episode


Personalized, targeted drugs and gene therapies are still at the forefront of medical innovation, as we discovered at RBC Capital Markets annual Doctor Days meetings. These insightful forums bring together key opinion leader clinicians and researchers from various therapeutic fields with institutional investors to discuss where opportunities lie, the next big breakthroughs, and the most novel drug therapies. Brian Abrahams, Gregory Renza, and Luca Issi join the podcast to discuss findings from the meetings.





More from YouTube